COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,803 Articles (22,527 medRxiv, 8,276 bioRxiv)

Most recent first Previous |  Page 188: Articles 1871-1880  | Next

Distal Protein-Protein Interactions Contribute to SARS-CoV-2 Main Protease Substrate Binding and Nirmatrelvir Resistance
Lewandowski, E. M., Zhang, X., Tan, H., Jaskolka-Brown, A., Kohaal, N., Frazier, A., Madsen, J. J., Jacobs, L. M. C., Wang, J., Chen, Y.
10.1101/2024.04.01.587566 — Posted: 2024-04-02
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Addetia, A., Stewart, C., Seo, A. J., Sprouse, K. R., Asiri, A. Y., Al-Mozaini, M., Memish, Z. A., Alshukairi, A., Veesler, D.
10.1101/2024.03.31.586409 — Posted: 2024-04-02
Biologically informed machine learning modeling of immune cells to reveal physiological and pathological aging process
Xia, Z., Zhang, B., Sun, L., Zhang, C., Ren, T., Zhao, X., Su, Y., Wang, Q., Zhang, T., He, B., Wu, L.-Y.
10.1101/2024.04.01.587649 — Posted: 2024-04-02
Single-cell analysis of lung epithelial cells reveals age and cell population-specific responses to SARS-CoV-2 infection in ciliated cells
Osborn, R. M., Anderson, C. S., Leach, J. R., Chu, C.-Y., Dewhurst, S., Mariani, T. J., Thakar, J.
10.1101/2024.04.02.587663 — Posted: 2024-04-02
CovTransformer: A transformer model for SARS-CoV-2 lineage frequency forecasting
Feng, Y., Goldberg, E. E., Kupperman, M., Zhang, X., Lin, Y., Ke, R.
10.1101/2024.04.01.24305089 — Posted: 2024-04-01
Older Age and Vaccination Protect Against Transaminase Elevation in Pediatric SARS-CoV2
Fernandez Ovalle, A., Charles, C., Rosenbaum, J. E., Villalba Davila, P., Mora, M., Sharma, S., Vega, V., Khandakar, S., Wallach, T.
10.1101/2024.04.01.24303996 — Posted: 2024-04-01
Robotic-inspired approach to multi-domain membrane receptor conformation space: theory and SARS-CoV-2 spike protein case study
Mathew, A. T., Sikora, M., Hummer, G., Mehdipour, A. R.
10.1101/2024.03.29.587391 — Posted: 2024-04-01
ViRNN: A Deep Learning Model for Viral Host Prediction
Sphabmixay, P., Lash, B.
10.1101/2024.03.30.587436 — Posted: 2024-04-01
Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2
Ehling, R. A., Minot, M., Overath, M. D., Sheward, D. J., Han, J., Gao, B., Taft, J. M., Pertseva, M., Weber, C. R., Frei, L., Bikias, T., Murrell, B., Reddy, S. T.
10.1101/2024.03.28.587189 — Posted: 2024-04-01
Broadly neutralizing antibodies against emerging delta-coronaviruses
Rexhepaj, M., Park, Y.-J., Perruzza, L., Asarnow, D., McCallum, M., Culap, K., Saliba, C., Leoni, G., Balmeli, A., Yoshiyama, C., Dickinson, M. S., Quispe, J., Brown, J. T., Tortorici, M. A., Sprouse, K. R., Taylor, A. L., Starr, T. N., Corti, D., Begnini, F., Veesler, D.
10.1101/2024.03.27.586411 — Posted: 2024-04-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).